SKI Market

Indian Indices

Sensex

85,567.48 638.12
( 0.75%)

Global Indices

Nasdaq

48,160.46 187.60
(0.39%)

Dow Jones

6,855.87 60.11
(0.88%)

Hang Seng

49,620.18 618.68
(1.26%)

Nikkei 225

9,885.23 47.46
(0.48%)

Forex

USD-INR

90.25 -0.22
(-0.24%)

EUR-INR

105.87 -0.28
(-0.27%)

GBP-INR

120.72 -0.26
(-0.21%)

JPY-INR

0.58 0.00
(-0.44%)

YOU ARE HERE :
HOME
Markets
Equity
Corporate Results - Detailed News

EQUITY - MARKET SCREENER

Back

Indrayani Biotech consolidated net profit declines 25.41% in the September 2025 quarter

16-Dec-25 07:38 Hrs IST

Net profit of Indrayani Biotech declined 25.41% to Rs 0.91 crore in the quarter ended September 2025 as against Rs 1.22 crore during the previous quarter ended September 2024. Sales rose 16.68% to Rs 35.95 crore in the quarter ended September 2025 as against Rs 30.81 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	35.95	30.81	17
OPM %	6.82	16.59	-
PBDT	2.36	3.99	-41
PBT	1.06	1.20	-12
NP	0.91	1.22	-25

85,567.48 638.12 ( 0.75%)

48,160.46 187.60 (0.39%)

6,855.87 60.11 (0.88%)

49,620.18 618.68 (1.26%)

9,885.23 47.46 (0.48%)

90.25 -0.22 (-0.24%)

105.87 -0.28 (-0.27%)

120.72 -0.26 (-0.21%)

0.58 0.00 (-0.44%)